Cite
The risk of covid-19 pandemic in patients with moderate to severe plaque psoriasis receiving systemic treatments
MLA
Gisondi, P., et al. The Risk of Covid-19 Pandemic in Patients with Moderate to Severe Plaque Psoriasis Receiving Systemic Treatments. 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1242039492&authtype=sso&custid=ns315887.
APA
Gisondi, P., Bellinato, F., Chiricozzi, A., Girolomoni, G., & Chiricozzi A. (ORCID:0000-0002-6739-0387). (2020). The risk of covid-19 pandemic in patients with moderate to severe plaque psoriasis receiving systemic treatments.
Chicago
Gisondi, P., F. Bellinato, Andrea Chiricozzi, G. Girolomoni, and Chiricozzi A. (ORCID:0000-0002-6739-0387). 2020. “The Risk of Covid-19 Pandemic in Patients with Moderate to Severe Plaque Psoriasis Receiving Systemic Treatments.” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1242039492&authtype=sso&custid=ns315887.